comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-05 03:01:08 - browse：5848

The back of three medicine containers, a bottle in between two boxes, all showing labels — coverage from STAT — Adobe

After a drug enters the market, it’s up to Food and Drug Administration regulators to ensure its continued safety and efficacy. A recent New York Times story suggests that, in the case of the popular asthma drug Singulair, the FDA fell short — both because the agency delayed action for years on reports from patient advocates and independent groups that the drug could cause suicidal thoughts, and because when it did add a warning label about its potential side effects in 2020, clinicians and patients still weren’t always aware of the risks.

Experts say that the Singulair incident highlights a flawed system, both in the U.S. and globally, for monitoring adverse reactions after a drug is on the market — one that will require extensive changes to address.

“The question is, how safe do you want to be?” said Ameet Sarpatwari, the assistant director of the Program on Regulation, Therapeutics, and Law at Brigham and Women’s Hospital. Ideally, he said, the FDA should be able to both stay on top of safety concerns and avoid unnecessarily restricting access to drugs. “Are we at the right balance? I think there are definitely situations for many drugs where you can say, no, we’re not really at the right balance, and the FDA should be taking a more aggressive stance in promoting patient safety.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Merck to buy EyeBio, maker of eye drug, as it grows pipeline

Wikipedia

WSS

Akili, maker of video game for ADHD, to be acquired for 34 million

Study: Black kids more likely to die after surgery than white kids

Medicare Advantage 2025 payments will dip, Biden administration says

Akili, maker of video game for ADHD, to be acquired for 34 million

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

Average age of first period drops to 11.9 years, study shows

knowledge

comprehensive

hotspot

The cancer drug shortage isn’t new — and neither are the solutions

First Opinion Podcast: What happens when kids become caregivers?

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Health insurers say they are turning to AI to cut costs, improve care

Virginia high school admissions case could be legal follow

Study: Black kids more likely to die after surgery than white kids

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Medicare Advantage 2025 payments will dip, Biden administration says

Drug repurposing or repositioning? The language matters

U.K. decision on ALS drug has neurologists, advocates up in arms

explore

Pancreatic cancer is often deadly, but new discoveries are raising hope

Scientific mystery highlights the blind spots in genomics databases

Mass General Brigham physicians react to latest merger step

Addiction doctors spar with methadone clinics over legislation

Addiction doctors spar with methadone clinics over legislation

Republican states more likely to report Covid vaccine side effects

hotspot

focus

Wikipedia

hotspot